Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lung Neoplasms × Nutrition Assessment × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Lung Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Cachexia 1 Breast Neoplasms 1 Body Weight 1

Interventions

Carboplatin 160 Cisplatin 98 Pemetrexed 89 Paclitaxel 89 Docetaxel 79 Gemcitabine 77 Radiotherapy 73 Erlotinib Hydrochloride 50 Bevacizumab 44 Etoposide 40 durvalumab 32 pembrolizumab 30 Magnetic Resonance Spectroscopy 25 Specimen Handling 23 Radiosurgery 23 Nivolumab 23 Gefitinib 23 Vinorelbine 21 Irinotecan 21 Topotecan 20 osimertinib 18 atezolizumab 16 Drug Therapy 16 Radiation 13 Neoadjuvant Therapy 13 Cetuximab 13 Surgical Procedures, Operative 12 Filgrastim 12 Celecoxib 12 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02019979 2018-05-04

METRO

Beth Israel Medical Center

Phase 2 Terminated

14 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡